Expression of functionally active cannabinoid receptor CB1 in the human prostate gland

Prostate

Volumn 54, Issue 2, 2003, Pages 95-102

  Ruiz Llorente, Lidia ^a   Sánchez, María G ^a   Carmena, María J ^a   Prieto, Juan C ^a   Sánchez Chapado, Manuel ^a,b   Izquierdo, Adriana ^a   Díaz Laviada, Inés ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

Author keywords

Adenylyl cyclase; Cannabinoids; CB1; GPCR receptors; Prostate

Indexed keywords

ADENYLATE CYCLASE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; PERTUSSIS TOXIN;

ADULT; AGED; ARTICLE; CEREBELLUM; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR CLONING; PRIORITY JOURNAL; PROSTATE; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEIN FAMILY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADENYLATE CYCLASE; AGED; BLOTTING, WESTERN; CANNABINOIDS; CEREBELLUM; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROSTATE; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0037305503     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10165     Document Type: Article

References (41)

1. Elphick MR, Egretova M. The neurobiology and evolution of cannabinoid signalling. Philos Trans R Soc Lond B Biol Sci 2001;356:381-408.
2. Ameri A. The effects of cannabinoids on the brain. Prog Neurobiol 1999;58:315-348.
3. Mechoulam R, Fride E, Di Marzo V. Endocannabinoids. Eur J Pharmacol 1998;359:1-18.
4. Breivogel CS, Griffin G, Di Marzo V, Martin BR. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol Pharmacol 2001;60:155-163.
5. Galiègue S, Mary S, Marchand J, Dussossoy D, Carrière D, Carayon P, Bouaboula M, Shire D, Le Fur G, Casellas P. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 1995;232:54-61.
6. Pertwee RG. Cannabinoids and the gastrointestinal tract. Gut 2001;48:859-867.
7. Prather PL, Martin NA, Breivogel CS, Childers SR. Activation of cannabinoid receptors in rat brain by WIN 55212-2 produces coupling to multiple G protein alpha-subunits with different potencies. Mol Pharmacol 2000;57:1000-1010.
8. Rhee M, Bayewitch M, Avidor-Reiss T, Levy R, Vogel Z. Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes. J Neurochem 1998;71:1525-1534.
9. Bouaboula M, Poinot-Chazel C, Bourrie B, Canat X, Calandra B, Rinaldi-Carmona M, Le Fur G, Cassellas P. Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem J 1995;312:637-641.
10. Bouaboula M, Poinot-Chazel C, Marchand J, Canat X, Bourrie B, Rinaldi-Carmona M, Calandra B, Le Fur G, Casellas P. Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression. Eur J Biochem 1996;273:704-711.
11. Galve-Roperh I, Sánchez C, Cortés ML, Gómez del Pulgar T, Izquierdo M, Guzmán M. Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat Med 2000;6:313-319.
12. Guzmán M, Galve-Roperh I, Sánchez C. Ceramide: a new second messenger of cannabinoid action. Trends Pharmacol Sci 2001;22:19-22.
13. Kunos G, Járai Z, Bátkai S, Goparaju SK, Ishac EJN, Liu J, Wang L, Wagner JA. Endocannabinoids as cardiovascular modulators. Chem Phys Lipids 2000;108:159-168.
14. Klein TW, Newton C, Friedman H. Cannabinoid receptors and immunity. Immunity Today 1998;19:373-381.
15. Murphy LL, Munoz RM, Adrian BA, Villanua MA. Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion. Neurobiol Dis 1998;5:432-446.
16. Wenger T, Toth BE, Juaneda C, Leonardelli J, Tramu G. The effects of cannabinoids on the regulation of reproduction. Life Sci 1999;65:695-701.
17. Wenger T, Ledent C, Csernus V, Gerendai I. The central cannabinoid receptor inactivation suppresses endocrine reproductive functions. Biochem Biophys Res Commun 2001;284:363-368.
18. Harclerode J. Endocrine effects of marijuana in the male: preclinical studies. NUDA Res Monogr 1984;44:46-64.
19. Gérard CM, Mollereau C, Vassart G, Parmentier M. Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem J 1991;279:129-134.
20. Schmid PC, Schwindenhammer D, Krebsbach RJ. Alternative pathways of anandamide biosynthesis in rat testes. Chem Phys Lipids 1998;92:27-35.
21. Greenfield SF, O'Leary G. Sex differences in marijuana use in the United States. Harvard Rev Psychiatry 1999;6:297-303.
22. Purohit V, Ahluwahlia BS, Vigersky RA. Marijuana inhibits dihydrotestosterone binding to the androgen receptor. Endocrinology 1980;107:848-850.
23. Ahluwalia BS, Rajguru SU, Nolan GH. The effect of THC inutero exposure on rat offspring fertility and ventral prostate gland morphology. J Androl 1985;6:386-391.
24. 9-Tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism. FEBS Lett 1999;458:400-404.
25. 1 cannabinoid receptor and Raf-1. Eur J Biochem 2001;268:531-535.
26. Melck D, de Petrocellis L, Orlando P, Bisogno T, Laezza C, Bifulco M, di Marzo V. Suppression of nerve growth factor Trk receptors and prolactin by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Endocrinology 1999;141:118-126.
27. Carmena MJ, Clemente C, Carrero I, Solano RM, Prieto JC. G proteins and β-adrenergic stimulation of adenylate cyclase activity in the diabetic rat prostate. Prostate 1997;33:46-54.
28. Gilman AG. A protein binding assay for adenosine 3′,5′-cyclic monophosphate. Proc Natl Acad Sci USA 1970;67:305-312.
29. Díaz-Laviada I, Larrodera P, D́az-Meco MT, Cornet ME, Guddal PH, Johansen T, Moscat J. Evidence for a role of phosphatidylcholine-hydrolysing phospholipase C in the regulation of protein kinase C by ras and src oncogenes. EMBO J 1990;9:3907-3912.
30. Bouaboula M, Bourrié B, Rinaldi-Carmona M, Shire D, Le Fur G, Casellas P. Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells. J Biol Chem 1995;270:13973-13980.
31. Shire D, Carillon C, Kaghad M, Calandra B, Rinaldi-Carmona M, Le Fur G, Caput D, Ferrara P. An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J Biol Chem 1995;270:3726-3731.
32. Porcella A, Maxia C, Gessa GL, Pani L. The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein. Eur J Neurosci 2000;12:1123-1127.
33. Barth F. Cannabinoid receptor agonists and antagonists. Exp Opin Ther Patents 1998;8:301-313.
34. Ottani A, Giuliani D. HU 210: a potent tool for investigations of the cannabinoid system. CNS Drug Rev 2001;7:131-145.
35. Vogel Z, Barg J, Levy R, Saya D, Heldman E, Mechoulam R. Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J Neurochem 1993;61:352-355.
36. 1 cannabinoid receptor in the brain. Neurobiol Dis 1998;5:405-416.
37. 1 receptor-G protein association. Eur J Biochem 2001;268:499-505.
38. Howlett AC, Fleminf M. Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. Mol Pharmacol 1984;26:532-538.
39. Das SK, Paria BC, Chakraborty I, Dey SK. Cannabinoid ligand-receptor signaling in the mouse uterus. Proc Natl Acad Sci USA 1995;92:4332-4336.
40. Schwindinger WF, Robishaw JD. Heterotrimeric G-protein betagamma-dimers in growth and differentiation. Oncogene 2001;20:1653-1660.
41. Kue PF, Daaka Y. Essential role for G proteins in prostate cancer cell growth and signaling. J Urol 2000;164:2162-2167.